putney

Putney Carprofen Caplets are a generic equivalent of Rimadyl® Caplets. Carprofen is prescribed to dogs for pain associated with canine osteoarthritis, and for controlling post-operative pain from certain surgeries.1 According to its manufacturer, Rimadyl® is the most prescribed non-steroidal anti-inflammatory drug (NSAID) for dogs. Putney provides a cost-saving equivalent to this popular prescription medicine.

Benefits:

• The same efficacy and safety: Putney Carprofen Caplets deliver the same efficacy and safety profile as Rimadyl® (carprofen) Caplets.
• The same high quality: Putney Carprofen is FDA-approved for use in dogs. It delivers the equivalent amount of active ingredient to the bloodstream in the same time period and meets all FDA bioequivalence requirements. Putney Carprofen Caplets are manufactured in FDA-inspected facilities using current Good Manufacturing Practices (cGMP).
• And more affordable: Lower cost enables pet owners to comply more easily with veterinarian recommendations. Affordable pricing also lowers inventory costs for veterinary practices.
• Dosage & Administration: Always provide client Information Sheet with prescription. Carefully consider the potential benefits and risk of Carprofen Caplets and other treatment options before deciding to use Carprofen Caplets. Use the lowest effective dose for the shortest duration consistent with indicidual response. The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Caplets are scored and dosage should be calculated in half-caplet increments.

Effectiveness Confirmationof the effectiveness of carprofen for the relief of pain and inflammation associated with osteoarthritis, and for the control of portoperative pain associated with soft tissue and orthopedic surgeries, was demonstrated in 7 placebo-controlled, masked studies examining the anti-inflammatory and analgesic effectiveness of carprofen caplets in various breeds of dogs.

Seperate placebo-controlled, masked, multicenter field studies confirmed the anti-inflammatory and anlgesic effectiveness of carprofen caplets when dosed at 2 mg/lb once daily or when divided and administered at 1mg/lb twice daily. In these 2 field studies, dogs diagnosed with osteoarthritis showed statistically significant overall improvement based on lameness evaluations by the veterinarian and owner observations when administered carprofen at labeled doses.

Seperate placebo-controlled, masked, multicenter field studies confirmed the effectiveness of carprofen caplets for the control of portoperative pain hwen dosed at 2 mg/lb oncr daily in various breeds of dogs. In these studies, dogs presented for ovariohysterectomy, cruciate repair and aural surgeries were administered carprofen preoperatively and for a maximum of 3 days (soft tissue) or 4 days (orthopedic) postoperatively. In general, dogs administered carprofen showed statiscally significant reduction in pain scores compared to controls.